Kidney shield? diabetes drug tested to prevent ICU kidney failure
Prevention
Terminated
This study tested whether dapagliflozin, a drug used for diabetes and chronic kidney disease, could prevent acute kidney injury in critically ill patients in the intensive care unit (ICU). The trial planned to enroll 3,000 adults but was terminated early after only 51 participant…
Phase: PHASE3 • Sponsor: The George Institute • Aim: Prevention
Last updated Jun 27, 2026 12:01 UTC